FDA clears Viz.ai algorithm for quantifying intracerebral hemmorhage

Viz.ai announced that it received FDA 510(k) clearance for its Viz ICH Plus algorithm for providing volume measurements of brain bleeds.

Viz ICH Plus automates the process of identifying, labeling and quantifying the volume of segmentable brain structures on non-contrast computed tomography (NCCT) images. The company designed it to analyze intracranial hyperdensities, lateral ventricles and midline shifts. These metrics help to enable timely and informed brain bleed treatment decisions.

San Francisco-based Viz.ai developed the algorithm for quantifying intracerebral hemorrhage. This type of hemorrhage accounts for up to 15% of all strokes, the company says, with high morbidity and mortality rates. It requires a swift response with accurate brain bleed measurements to assess the severity of cases and monitor progression.

Sign up for Blog Updates